Advertisement

M*Modal Company Profile

19:39 EDT 18th June 2013 | BioPortfolio

M*Modal, the market leader in advanced Speech Understanding technology, combines industry leading technology and clinical documentation services to produce highly accurate, structured, encoded and shareable medical documents to facilitate the use and adoptability of electronic health records. More than 800 healthcare organizations nationwide utilize M*Modal’s solutions to increase patient safety and promote continuity of patient care. For more information, please visit www.mmodal.com.


News Articles [ 63 Associated News Articles listed on BioPortfolio]

UPDATE 1-One Equity acquires M*Modal for $1.1 bln

* Says deal at a premium of 8.3 pct to M*Modal's Monday close

REFILE-UPDATE 2-One Equity to buy M*Modal for $1.1 bln

* Says deal at a premium of 8.3 pct to M*Modal's Monday close

UPDATE 2-One Equity to buy M*Modal for $1.1 bln

* Says deal at a premium of 8.3 pct to M*Modal's Monday close

M Modal to be acquired by One Equity Partners for $1.1 billion

M Modal and One Equity Partners have entered into a definitive agreement pursuant to which One Equity Partners, the private investment arm of JP Morgan Chase & Co., will acquire all of the outstan...

EHR and HIT News for May 21st

Today’s EHR and HIT news includes customer acquisition updates from M*Modal  and Merge Healthcare, as well as news from DocuTrac that they’re integrating DrFirst Technology in their EMR S...

M*Modal Announces Strategic Alliance With 3M Health Information Systems

M*Modal, a leading provider of clinical documentation and speech understanding solutions, announced in a press release an agreement with 3M Health Information Systems enabling the M*Modal clinical doc...

Wellmont Health System Selects M*Modal for Advanced Speech Understanding Solutions

M*Modal, a leading provider of clinical documentation and Speech Understanding solutions, announced in a press release an expanded relationship with Wellmont Health System to deliver exclusive enterpr...

M*Modal Announces Strategic Alliances

M*Modal, a leading provider of clinical documentation and Speech Understanding™ solutions, announced a strategic alliance with Optum to deliver front-end speech understanding technology to a wid...

Drugs and Medications [ 2 Associated Drugs and Medications listed on BioPortfolio]

Risperidone [WOCKHARDT LIMITED]

These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone. Risperidone Tablets Initial U.S. Approval : 1993

Risperidone [WOCKHARDT USA LLC]

These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone. Risperidone Tablets Initial U.S. Approval : 1993

PubMed Articles [ 86 Associated PubMed Articles listed on BioPortfolio]

MECHANISMS OF CROSS-MODAL PLASTICITY IN EARLY BLIND SUBJECTS.

A variety of studies have demonstrated enhanced BOLD responses to auditory and tactile stimuli within occipital cortex as a result of early blindness. However, little is known about the organizational...

Cross-modal versus within-modal recall: differences in behavioral and brain responses.

Although human experience is multisensory in nature, previous research has focused predominantly on memory for unisensory as opposed to multisensory information. In this work, we sought to investigate...

An event-related potential study on cross-modal conversion of Chinese characters.

In the current study, we explored the effects of ERPs (event-related potentials), related to the cross-modal transfer from visual input to phonological retrieval. Using Chinese single-character words,...

The perceptual nature of the cross-modal priming effect: arguments in favor of a sensory-based conception of memory.

The aim of this study was to demonstrate that the cross-modal priming effect is perceptual and therefore consistent with the idea that knowledge is modality dependent. We used a two-way cross-modal pr...

Sub-threshold cross-modal sensory interaction in the thalamus: lemniscal auditory response in the medial geniculate nucleus is modulated by somatosensory stimulation.

Recent studies have highlighted cross-modal sensory modulations in the primary sensory areas in the cortex, suggesting that cross-modal sensory interactions occur at early stages in the hierarchy of s...

Clinical Trials [ 12 Associated Clinical Trials listed on BioPortfolio]

Cortical Visual Impairment and Visual Attentiveness

This study will investigate the effect of enhanced visual and cross-modal environments upon the visual attentiveness of multiply handicapped children diagnosed with Cerebral Palsy (CP) and...

Improving Care of Osteoporosis: Multi-Modal Intervention to Increase Testing and Treatment (ICOMMIITT)

The purpose of this study is to rigorously test the incremental impact of simple, generalizable interventions to improve healthcare among older women at high risk for osteoporosis. Buildin...

A Smoking, Alcohol, and Depression Intervention for Head and Neck Cancer

Data from the Surveillance, Epidemiology and End Results (SEER) cancer registry indicates that head and neck cancers (HN Ca) are nearly twice as common in veterans as non-veterans. HN Ca p...

Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma

This is a phase II study of induction chemotherapy (capecitabine, oxaliplatin and cetuximab (erbitux)) followed by capecitabine, oxaliplatin, cetuximab and radiotherapy followed by surgery...

Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring

The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to determine t...

Companies [ 10 Associated Companies listed on BioPortfolio]

M*Modal

M*Modal, the market leader in advanced Speech Understanding technology, combines industry leading technology and clinical documentation services to produce highly accurate, struct...

M*Modal and MedQuist Holdings

M*Modal is a leading provider of clinical narrative capture services, Speech Understanding technology and clinical documentation workflow. M*Modal’s enterprise solutions â€...

M*Modal Inc.

M*Modal (NASDAQ/GS: MODL) is a leading provider of clinical narrative capture services, Speech Understanding™ technology and clinical documentation workflow. M*Modal’s e...

APD Dynamics Incorporated

APS DYNAMICS, INC. based in Carlsbad, California specializes in designing, manufacturing and marketing vibration systems for modal test excitation, low frequency calibration and component test. Produc...

APS DYNAMICS, INC

APS DYNAMICS, INC. based in Carlsbad, California specializes in designing, manufacturing and marketing vibration systems for modal test excitation, low frequency calibration and component test. Produc...

More Information about "M*Modal" on BioPortfolio

We have published hundreds of M*Modal news stories on BioPortfolio along with dozens of M*Modal Clinical Trials and PubMed Articles about M*Modal for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of M*Modal Companies in our database. You can also find out about relevant M*Modal Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement